AbbVie Inc.ABBV
NYSE•Healthcare•Drug Manufacturers - General
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $62.82B, growing 9.5% year-over-year. TTM net income stood at $3.63B (13.3% contraction). Quarterly EBITDA was $5.93B and operating income was $3.99B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze ABBV growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters